![Nicholas Virca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Virca
Directeur Général chez
Hedgepath LLC
Fortune : 776 749 $ au 31/08/2026
Profil
Nicholas Jon Virca is currently the President, Chief Executive Officer & Director at Hedgepath LLC since 2012.
Previously, he held the position of President & Chief Executive Officer at Mast Therapeutics, Inc. from 1997 to 2004.
He also served as the President & Chief Executive Officer at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Additionally, he worked as a Director at Panoptix Events from 2007 to 2017 and as a Director at Diametrix Detectors, Inc. from 1991 to 1997.
Furthermore, he held the role of Vice President-Global Biotechnology at Pall Corp.
and Cytiva US LLC from 2005 to 2008.
Lastly, he served as the Chief Operating Officer at LamdaGen Corp.
from 2008 to 2012.
Mr. Virca obtained his undergraduate degree from Youngstown State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/08/2026 | 8 727 519 ( 5,02 % ) | 776 749 $ | 31/08/2026 |
Postes actifs de Nicholas Virca
| Sociétés | Poste | Début |
|---|---|---|
Hedgepath LLC | Directeur Général | 01/04/2012 |
Anciens postes connus de Nicholas Virca
| Sociétés | Poste | Fin |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Directeur Général | 13/12/2022 |
Panoptix Events
 Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Directeur/Membre du Conseil | 01/01/2017 |
LamdaGen Corp.
 LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Directeur des opérations | 01/04/2012 |
| PALL CORPORATION | Corporate Officer/Principal | 01/01/2008 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Corporate Officer/Principal | 01/01/2008 |
Formation de Nicholas Virca
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Pall Corp.
 Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Hedgepath LLC | |
Youngstown State University
 Youngstown State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Health Technology |
LamdaGen Corp.
LamdaGen Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary biosensors and instruments | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Panoptix Events
Panoptix Events Miscellaneous Commercial ServicesCommercial Services Operates as a event planning agency | Commercial Services |
Diametrix Detectors, Inc. |
